[HTML][HTML] Global pandemics interconnected—obesity, impaired metabolic health and COVID-19
Obesity and impaired metabolic health are established risk factors for the non-
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …
[HTML][HTML] COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
[HTML][HTML] Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
Background & Aims Chronic liver disease (CLD) and cirrhosis are associated with immune
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
Pathophysiological mechanisms of liver injury in COVID‐19
AD Nardo, M Schneeweiss‐Gleixner… - Liver …, 2021 - Wiley Online Library
The recent outbreak of coronavirus disease 2019 (COVID‐19), caused by the Severe Acute
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide …
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide …
[HTML][HTML] NETosis and neutrophil extracellular traps in COVID-19: immunothrombosis and beyond
Y Zhu, X Chen, X Liu - Frontiers in Immunology, 2022 - frontiersin.org
Infection with SARS-CoV-2, the causative agent of the Coronavirus disease 2019 (COVID-
19) pandemic, causes respiratory problems and multifaceted organ dysfunction. A crucial …
19) pandemic, causes respiratory problems and multifaceted organ dysfunction. A crucial …
[HTML][HTML] Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data
The novel coronavirus SARS-CoV-2 (coronavirus disease 19, or COVID-19) primarily
causes pulmonary injury, but has been implicated to cause hepatic injury, both by serum …
causes pulmonary injury, but has been implicated to cause hepatic injury, both by serum …
[HTML][HTML] Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and
ESCMID published a position paper to provide guidance for physicians involved in the care …
ESCMID published a position paper to provide guidance for physicians involved in the care …
Cholangiopathy after severe COVID-19: clinical features and prognostic implications
S Faruqui, FC Okoli, SK Olsen… - Official journal of the …, 2021 - journals.lww.com
METHODS: We conducted a retrospective study of COVID-19 patients admitted to our
institution from March 1, 2020, to August 15, 2020, on whom the hepatology service was …
institution from March 1, 2020, to August 15, 2020, on whom the hepatology service was …
[HTML][HTML] COVID-19 and the vasculature: current aspects and long-term consequences
B Martinez-Salazar, M Holwerda, C Stuedle… - Frontiers in cell and …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …
Invited Review: The spectrum of neuropathology in COVID‐19
S Al‐Sarraj, C Troakes, B Hanley… - Neuropathology and …, 2021 - Wiley Online Library
There is increasing evidence that patients with Coronavirus disease 19 (COVID‐19) present
with neurological and psychiatric symptoms. Anosmia, hypogeusia, headache, nausea and …
with neurological and psychiatric symptoms. Anosmia, hypogeusia, headache, nausea and …